Neurofibromatosis Type 1 (NF1) with Cutaneous Neurofibromas

Neurofibromatosis Type 1 (NF1) with Cutaneous Neurofibromas

Neurofibromatosis Type 1 NF1 with Cutaneous Neurofibromas

Skin Care Research is not currently enrolling participants for a Neurofibromatosis type I (NF1)clinical trial. Qualified participants will receive all study-related care provided by board-certified dermatologists at one of our partnered clinics. All Skin Care Research studies are in compliance with FDA guidelines and uphold the highest clinical standards.

Please fill out a form on this page for future trials or call 561-948-3116.


Neurofibromatosis type I (NF1) Clinical Trials: What is Neurofibromatosis type I (NF1)?

Neurofibromatosis type 1 (NF1), also known as von Recklinghausen disease, is a genetic disorder that primarily affects the nervous system. It is a relatively common genetic condition, occurring in about 1 in every 3,000 to 4,000 individuals worldwide. NF1 is caused by mutations in the NF1 gene, which is responsible for producing a protein called neurofibromin.

The main characteristic feature of NF1 is the development of multiple benign tumors called neurofibromas. These tumors grow along the nerves anywhere in the body and can vary in size and location. They may appear as soft, fleshy bumps on or under the skin, or as deeper tumors affecting internal organs. Neurofibromas are typically non-cancerous, but in some cases, they may become malignant.

About Skin Care Research

As a clinical research center with over 25 years of experience in the execution of dermatological and cosmetic clinical trials, Skin Care Research has conducted hundreds of successful research studies for trusted brands including Abbvie, Eli Lilly, Galderma, Pfizer Inc, and more. Our research staff and board-certified dermatologists are highly trained and experienced in conducting FDA approved clinical trials.

Skin Care Research conducts phase 2 through phase 4 clinical trials with patient safety being the number one priority. To learn more about our enrolling studies, including time commitment, participant responsibilities, and other things you should expect, fill out the form or give us a call at 561-948-3116.